UPDATE : Friday, December 6, 2019
상단여백
Bristol-Myers Squibb Korea names new CEO by Lee Han-soo 2019-11-28 11:26
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease by Lee Han-soo 2019-11-27 18:21
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics by Lee Han-soo 2019-11-26 18:48
Amgen releases analysis result showing benefits of LDL-C treatment by Lee Han-soo 2019-11-26 17:05
라인
Roche’s flu treatment Xofluza wins approval by Kim Yun-mi 2019-11-26 16:08
Immunotherapies give hope for esophageal cancer patients by Kim Yun-mi 2019-11-26 15:37
GC Labcell hands over NK cell-treating tech to US lab by Lee Han-soo 2019-11-26 15:33
SK Biopharm to speed up global advance through XCOPRI’s launch by Lee Han-soo 2019-11-26 14:16
Huons Global wins KGMP certification for BTX plant by Lee Han-soo 2019-11-25 16:00
라인
Gtree enrolls 200 patients for US trial of dry eye treatment by Lee Han-soo 2019-11-25 14:49
Daewoong renews EU GMP certification for BTX plant by Lee Han-soo 2019-11-25 11:55
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently by Lee Han-soo 2019-11-22 17:03
Bridge Biotherapeutics aims to become global NRDO company by Lee Han-soo 2019-11-22 15:10
‘SGLT-2 inhibitor may prevent retinopathy in type-2 diabetes’ by Lee Han-soo 2019-11-21 15:21
라인
‘Sprycel showed longer efficacy than nilotinib for chronic myeloid leukemia’ by Lee Han-soo 2019-11-21 14:26
CJ HealthCare to export gastric acid blocker to Thailand by Lee Han-soo 2019-11-21 10:54
‘Japan much advanced than Korea in ALK-positive NSCLC treatment’ by Kim Yun-mi 2019-11-20 16:16
Remed aims to expand global presence through IPO by Lee Han-soo 2019-11-20 15:30
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab by Jeong Sae-im 2019-11-19 17:18
여백
여백
여백
Back to Top